Encompass Health jumps 7.5% as Q1 results and raised 2026 outlook boost sentiment

Encompass Health (EHC) is up 7.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is investor reaction to Encompass Health’s first-quarter 2026 earnings update, which featured solid profitability and an increased full-year outlook. A guidance raise can matter more than a modest quarterly beat because it suggests stronger underlying volumes, pricing, and/or cost execution than the market had modeled.

Details:

Encompass Health reported first-quarter 2026 results for the period ended March 31, 2026, and highlighted performance that topped typical Wall Street expectations for the quarter.

The company reported first-quarter net income of about $194.5 million, signaling continued earnings power in its inpatient rehabilitation hospital business.

Full-year 2026 guidance was increased, with earnings expected in the range of roughly $5.89 to $6.11 per share and revenue expected around $6.38 billion to $6.47 billion.

Management’s earnings-call materials emphasized ongoing growth trends (including revenue growth) and reinforced confidence in the 2026 plan, which likely helped drive buying interest.

Sources:

Encompass Health (press release), Associated Press, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$EHC Insider Trading Activity

$EHC insiders have traded $EHC stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $EHC stock by insiders over the last 6 months:

MARK J TARR (President & CEO) has made 0 purchases and 7 sales selling 150,000 shares for an estimated $16,746,688.
EDMUND FAY (Sr. Vice Pres. and Treasurer) sold 11,937 shares for an estimated $1,277,259
PATRICK WILLIAM TUER (EVP, Chief Operating Officer) sold 2,804 shares for an estimated $301,766

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

$EHC Hedge Fund Activity

We have seen 265 institutional investors add shares of $EHC stock to their portfolio, and 325 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 3,793,358 shares (+3059159.7%) to their portfolio in Q4 2025, for an estimated $402,627,018
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,032,136 shares (-77.8%) from their portfolio in Q4 2025, for an estimated $109,550,915
PRICE T ROWE ASSOCIATES INC /MD/ added 948,202 shares (+24.6%) to their portfolio in Q4 2025, for an estimated $100,642,160
POINT72 ASSET MANAGEMENT, L.P. added 695,147 shares (+165511.2%) to their portfolio in Q4 2025, for an estimated $73,782,902
ALLIANCEBERNSTEIN L.P. removed 649,110 shares (-25.8%) from their portfolio in Q4 2025, for an estimated $68,896,535
FMR LLC removed 617,965 shares (-58.7%) from their portfolio in Q4 2025, for an estimated $65,590,805
WELLINGTON MANAGEMENT GROUP LLP added 603,472 shares (+21.7%) to their portfolio in Q4 2025, for an estimated $64,052,518

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$EHC Congressional Stock Trading

Members of Congress have traded $EHC stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $EHC stock by members of Congress over the last 6 months:

REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 10/31.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.